Candidacidal activity of macrophages from immunocompetent and congenitally immunodeficient mice

Journal of Infectious Diseases

Volumn 170, Issue 1, 1994, Pages 180-188

  Vazquez Torres, Andres ^a   Jones Carson, Jessica ^a   Balish, Edward ^a   Mishkin, Eric M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; FLUORESCEIN; GAMMA INTERFERON; ISOTHIOCYANIC ACID;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CANDIDIASIS; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PERITONEUM EXUDATE; PHAGOCYTOSIS; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANALYSIS OF VARIANCE; ANIMAL; CANDIDA ALBICANS; CELLS, CULTURED; CHEMOTAXIS; CONCANAVALIN A; HEAT; IMMUNOCOMPETENCE; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, NUDE; MUTATION; PHAGOCYTOSIS; SUPEROXIDE DISMUTASE; SUPPORT, U.S. GOV'T, P.H.S.; THIOGLYCOLATES;

EID: 0028339808     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/170.1.180     Document Type: Article

References (47)

1. Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med 1984;77:20-7.
2. Clift RA. Candidiasis in the transplant patient. Am J Med 1984;77:34-8.
3. Hostetter MR. Perspective in diabetes. Handicaps to host defense. Ef fects of hyperglycemia on C3 and C. albicans. Diabetes 1990; 39:271-5.
4. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oralcandidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311:354-8.
5. Schuit KE. Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect Immun 1979;24:932-8.
6. Baldwin GC, Fleischmann J, Chung Y, Koyanagi Y, Chen IS, Golde DW. Human immunodeficiency virus causes mononuclear phagocyte dysfunction. Proc Natl Acad Sci USA 1990;87:3933-7.
7. Ashman RB, Papadimitriou JM. What’s new in the mechanisms of hostresistance to Candida albicans infection? Pathol Res Pract 1990;186:527-34.
8. Baccarini M, Bistoni F, Lohmann-Matthes ML. In vitro natural cell-mediated cytotoxicity against Candida albicans: Macrophage precursors as effector cells. J Immunol 1985;134:2658-65.
9. Bistoni F, Vecchiarelli A, Cenci E, Puccetti P, Marconi P, Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun 1986;51:668-74.
10. Baghian A, Lee KW. Role of activated macrophages in resistance to systemic candidosis. J Leukoc Biol 1988;44:166-71.
11. Jensen J, Vazquez-Torres A, Balish E. Poly(I.C)-induced interferons enhance susceptibility ofSCID mice to systemic candidiasis. Infect Immun 1992;60:4549-57.
12. Nottet HS, deGraaf L, deVos NM, et al. Phagocytic function of mono cyte-derived macrophages is not affected by human immunodeficiency virus type I infection. J Infect Dis 1993;168:84-91.
13. Capsoni F, Minonzio F, Ongari AM, Rizzardi GP, Lazzarin A, Zanussi C. Monocyte-derived macrophage function in HIV-infected subjects: In vitro modulation by rIFN-y and rGM-CSF. Clin Immunol Im-munopathol 1992;62:176-82.
14. Levy MH, Wheelock EF. Effects of intravenous silica on immune and nonimmune functions of the murine host. J Immunol 1975; 115:41-8.
15. Lee KW, Balish E. Systemic candidosis in silica-treated athymic and euthymic mice. Infect Immun 1983;41:902-7.
16. Baghian A, Lee KW. Systemic candidosis in beige mice. J Med Vet Mycol 1989;27:51-5.
17. Rogers TL, Balish E. The role of activated macrophages in resistance to experimental, renal candidiasis. J Reticuloendothel Soc 1977;22: 309-18.
18. Mahanty S, Greenfield RA., Joyce WA., Kincade PW. Inoculation can didiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun 1988;56:3162-6.
19. Cutler JE. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J Reticuloendothel Soc 1976;19:121-4.
20. Ashman RB. Papadimitriou JM. Susceptibility of beige mutant mice to candidiasis may be linked to a defect in granulocyte production by bone marrow stem cells. Infect Immun 1991;59:2140-6.
21. Marquis G, Montplaisir S, Pelletier M, Mousseau S, Auger P. Strain-de pendent differences in susceptibility of mice to experimental candi-dosis. J Infect Dis 1986;154:906-9.
22. Cantorna MT, Balish E. Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis 1991;164:936-43.
23. Roder JC., Lohmann-Matthes ML, Domzig W, Wigzell H. The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol 1979;123:2174-81.
24. Oliver C. Essner E. Formation of anomalous lysosomes in monocytes, neutrophils, and eosinophils from bone marrow of mice with Che-diak-Higashi syndrome. Lab Invest 1975;32:17-27.
25. Wolff SM, Dale DC, Clark RA., Root RK, Kimball HR. The Chediak-Higashi syndrome: Studies of host defenses. Ann Intern Med 1972;76:293-306.
26. Cantorna MT, Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 1990;58:1093-100.
27. Molina IJ, Huber BT. Regulation of macrophage activation markers by IL-4 and IFN-7 is subpopulation-specific. Cell Immunol 1991; 134:241-8.
28. Fattorossi A. Nisini R, Pizzolo JG, D’Amelio R. New, simple flow cytometry technique to discriminate between internalized and membrane-bound particles in phagocytosis. Cytometry 1989;10:320-5.
29. Cenci E. Bartocci A, Puccetti P, Mocci S, Stanley ER. Bistoni F. Macro phage colony-stimulating factor in murine candidiasis: Serum and tissue levels during infection and protective effect of exogenous administration. Infect Immun 1991;59:868-72.
30. Cenci E, Romani L., Mencacci A, et al. lnterleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993;23:1034-8.
31. Hidore MR, Murphy JW. Natural cellular resistance of beige mice against Crvptococcus neoformans. J Immunol 1986;137:3624-31.
32. Salkowski CA, Balish E. Cryptococcosis in beige mice: The effect of congenital defects in innate immunity on susceptibility. Can J Microbiol 1991;37:128-35.
33. Brummer E, Stevens DA. Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or 7-interferon. J Med Microbiol 1989;28:173-81.
34. Marodi L, Forehand JR, Johnston RB Jr. Mechanisms of host defenseagainst Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol 1991;146:2790-4.
35. Sasada M, Johnston RB. Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med 1980;152:85-98.
36. Redmond HP, Shou J, Gallagher HJ, Kelly CJ, Daly JM. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. J Immunol 1993;150:3427-33.
37. Clerici M, Shearer GM. A Th I >Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-11.
38. Garner RE, Kuruganti U, Czarniecki CW, Chiu HH, Domer JE. In vivoimmune responses to Candida albicans modified by treatment with recombinant murine 7 interferon. Infect Immun 1989;57:1800-8.
39. Cantorna MT, Balish E. Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect Immun 1991;59:2447-55.
40. Patino MM, Williams D, Ahrens J, Graybill JR. Experimental histo plasmosis in the beige mouse. J Leukoc Biol 1987;41:228-35.
41. Fontana A, Constam DB, Frei K, Malipiero U, Pfister H W. Modulation of the immune response by transforming growth factor ß. lnt Arch Allergy Immunol 1992;99:1-7.
42. Smith PD, Lamerson CL, Banks SM, et al. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis 1990;161:999-1005.
43. Thompson HL, Wilton JM. Interaction and intracellular killing of Can dida albicans blastospores by human polymorphonuclear leucocytes, monocytes and monocyte-derived macrophages in aerobic and anaerobic conditions. Clin Exp Immunol 1992;87:316-21.
44. Lorsbach RB, Russell SW. A specific sequence of stimulation is required to induce synthesis of the antimicrobial molecule nitric oxide by mouse macrophages. Infect Immun 1992;60:2133-5.
45. Stuehr DJ, Marietta MA. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-7. J Immunol 1987;139:518-25.
46. Adams LB, Hibbs JB Jr, Taintor RR, Krahenbuhl JL. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 1990;144:2725-9.
47. Marquis G, Montplaisir S. Pelletier M, Auger P, Lapp WS. Genetics of resistance to infection with Candida albicans in mice. Br J Exp Pathol 1988;69:651-60.